Developing PRDM Gene and Protein Modulation Agents as Anti-Cancer Products
Personalized management of sepsis
The mission of IROA Technologies is to simplify our customer's metabolomics research.
Founded in 1995, Meso Scale Discovery (MSD) is a leader in the development, manufacture, and commercialization of innovative assays and instruments for the measurement of molecules in biological ...
Myriad RBM develops and sells immunoassays to measure biomarkers in blood.
NeuroPointDX, through its compound safety screening division Stemina Biomarker Discovery, has developed the leading metabolomics platform for ...
Biomarker Identification, Drugs
Biomarker testing services
Biomarker Discovery & Lipidomic Services